Because monoclonal antibodies are the foundation of QED’s business, we never stop looking for new ways to improve our procedures for creating hybridomas and producing antibodies. As a result, our scientists continually evaluate key reagents from multiple suppliers and use only those that support the greatest yields of hybridoma cell lines and antibody products. We now make these pre-screened reagents available to our customers in QED Antibody Production Kits.
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.